Understanding IL-27 Complex: Potential Drug Targets and Biomarkers

Target Name: Interleukin-27 (IL-27) Complex

NCBI ID: P31183

Other Name(s): IL-27 | IL-27 complex | Interleukin 27

Understanding IL-27 Complex: Potential Drug Targets and Biomarkers

Interleukin-27 (IL-27) Complex is a protein that plays a crucial role in the immune system and has been linked to a number of diseases, including autoimmune disorders, cancer, and obesity. Despite its importance, little is known about the underlying biology of IL-27 Complex, making it an attractive drug target or biomarker. In this article, we will explore the biology of IL-27 Complex and its potential as a drug target.

The IL-27 Complex is a protein complex that consists of several subunits, including IL-27A, IL-27B, IL-27C, and IL-27D. These subunits are held together by disulfide bonds and form a monomeric complex. The IL- 27A subunit is the primary receptor for IL-27, and it is expressed in various tissues throughout the body, including the skin, gut, and lymphoid organs. The IL-27B subunit is a scaffold protein that helps to maintain the structure of the IL -27 complex. The IL-27C subunit is a type of transmembrane protein that is involved in the regulation of ion channels and is expressed in the brain and other tissues. The IL-27D subunit is a cytoplasmic protein that is involved in the regulation of cell adhesion and is expressed in various tissues, including the placenta and the liver.

The biology of IL-27 Complex is complex and involves multiple signaling pathways. One of the most well-established signaling pathways involves the T cell signaling pathway. T cells are a critical part of the immune system and play a crucial role in fighting off infections and cancer. IL-27 is involved in the regulation of T cell development, activation, and differentiation. Studies have shown that IL-27 can promote the growth and survival of naive T cells and can also stimulate the production of memory T cells.

Another signaling pathway that is involved in the IL-27 Complex is the production of pro-inflammatory cytokines. These cytokines, such as TNF-伪, IL-1尾, and IL-6, are involved in the regulation of inflammation and immune responses. The IL-27 Complex is involved in the production of these cytokines and can also be regulated by them. For example, the production of IL-6 by the IL-27 Complex is regulated by the cytokine PD-1.

IL-27 is also involved in the regulation of cellular processes that are important for the development and maintenance of cancer. For example, the IL-27 Complex has been shown to promote the growth and survival of various cancer cell types, including breast, lung , and ovarian cancer cells. The role of IL-27 in cancer development is still not well understood, but it is possible that it may play a negative role in the regulation of tumor progression and the development of resistance to chemotherapy.

In addition to its role in cancer development, IL-27 is also involved in the regulation of autoimmune disorders. The IL-27 Complex has been shown to promote the production of immune cells, including T cells and B cells, which are involved in the regulation of autoimmune responses. The production of IL-27 by the immune cells is regulated by various cytokines, including IL-10 and IL-12.

The potential drug targets for IL-27 Complex are numerous and varied. One of the most promising targets is the use of IL-27 inhibitors to treat autoimmune disorders. The use of IL-27 inhibitors has been shown to be effective in treating a variety of autoimmune disorders, including rheumatoid arthritis, lupus, and multiple sclerosis. In addition to the use of IL-27 inhibitors, another potential drug target for IL-27

Protein Name: Interleukin-27 (IL-27) Complex

More Common Targets